72 related articles for article (PubMed ID: 10022355)
1. Molecular dynamics study of the proposed beta-hairpin form of the switch domain from HIV1 gp120 alone and complexed with an inhibitor of CD4 binding.
Graf von Stosch A; von der Lieth CW; Reed J
Proteins; 1999 Feb; 34(2):197-205. PubMed ID: 10022355
[TBL] [Abstract][Full Text] [Related]
2. NMR studies on the conformation of the CD4 36-59 peptide bound to HIV-1 gp120.
Gizachew D; Moffett DB; Busse SC; Westler WM; Dratz EA; Teintze M
Biochemistry; 1998 Jul; 37(30):10616-25. PubMed ID: 9692951
[TBL] [Abstract][Full Text] [Related]
3. Extension of the polarity-dependent "switch phenomenon" of the gp120 binding domain as a target for antiviral chemotherapy.
Graf von Stosch A; Kinzel V; Reed J
Biochemistry; 1996 Jan; 35(2):411-7. PubMed ID: 8555210
[TBL] [Abstract][Full Text] [Related]
4. Successful design and synthesis of a polarity-triggered beta-->alpha conformational switch using the side chain interaction index (SCII) as a measure of local structural stability.
Gehenn K; Pipkorn R; Reed J
Biochemistry; 2004 Jan; 43(3):607-12. PubMed ID: 14730964
[TBL] [Abstract][Full Text] [Related]
5. How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors.
Hamza A; Zhan CG
J Phys Chem B; 2006 Feb; 110(6):2910-7. PubMed ID: 16471901
[TBL] [Abstract][Full Text] [Related]
6. Atomic insight into the CD4 binding-induced conformational changes in HIV-1 gp120.
Hsu ST; Bonvin AM
Proteins; 2004 May; 55(3):582-93. PubMed ID: 15103622
[TBL] [Abstract][Full Text] [Related]
7. Conformational study of fragments of envelope proteins (gp120: 254-274 and gp41: 519-541) of HIV-1 by NMR and MD simulations.
Kanyalkar M; Srivastava S; Saran A; Coutinho E
J Pept Sci; 2004 Jun; 10(6):363-80. PubMed ID: 15214441
[TBL] [Abstract][Full Text] [Related]
8. Solvent polarity-dependent structural refolding: a CD and NMR study of a 15 residue peptide.
Graf von Stosch A; Jiménez MA; Kinzel V; Reed J
Proteins; 1995 Oct; 23(2):196-203. PubMed ID: 8592701
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and evaluation of potential inhibitors of HIV gp120-CD4 interactions.
Boussard C; Klimkait T; Mahmood N; Pritchard M; Gilbert IH
Bioorg Med Chem Lett; 2004 May; 14(10):2673-6. PubMed ID: 15109676
[TBL] [Abstract][Full Text] [Related]
10. Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.
Rosen O; Chill J; Sharon M; Kessler N; Mester B; Zolla-Pazner S; Anglister J
Biochemistry; 2005 May; 44(19):7250-8. PubMed ID: 15882063
[TBL] [Abstract][Full Text] [Related]
11. CD4 binding partially locks the bridging sheet in gp120 but leaves the beta2/3 strands flexible.
Pan Y; Ma B; Nussinov R
J Mol Biol; 2005 Jul; 350(3):514-27. PubMed ID: 15946678
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for the interaction between focal adhesion kinase and CD4.
Garron ML; Arthos J; Guichou JF; McNally J; Cicala C; Arold ST
J Mol Biol; 2008 Feb; 375(5):1320-8. PubMed ID: 18078954
[TBL] [Abstract][Full Text] [Related]
13. Is the V3 loop involved in HIV binding to CD4?
Dettin M; Ferranti P; Scarinci C; Picariello G; Di Bello C
Biochemistry; 2003 Aug; 42(30):9007-12. PubMed ID: 12885233
[TBL] [Abstract][Full Text] [Related]
14. Molecular modeling on human CCR5 receptors and complex with CD4 antigens and HIV-1 envelope glycoprotein gp120.
Yang J; Liu CQ
Acta Pharmacol Sin; 2000 Jan; 21(1):29-34. PubMed ID: 11263244
[TBL] [Abstract][Full Text] [Related]
15. Primary structure elements responsible for the conformational switch in the envelope glycoprotein gp120 from human immunodeficiency virus type 1: LPCR is a motif governing folding.
Reed J; Kinzel V
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6761-5. PubMed ID: 8341695
[TBL] [Abstract][Full Text] [Related]
16. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
Barbouche R; Decroly E; Kieny MP; Fenouillet E
Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
[TBL] [Abstract][Full Text] [Related]
17. A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120.
Neffe AT; Meyer B
Angew Chem Int Ed Engl; 2004 May; 43(22):2937-40. PubMed ID: 15170309
[No Abstract] [Full Text] [Related]
18. Investigation of the structural components governing the polarity-dependent refolding of a CD4-binding peptide from gp120.
Graf von Stosch A; Kinzel V; Pipkorn R; Reed J
J Mol Biol; 1995 Jul; 250(4):507-13. PubMed ID: 7616571
[TBL] [Abstract][Full Text] [Related]
19. Peptide T revisited: conformational mimicry of epitopes of anti-HIV proteins.
Picone D; Rivieccio A; Crescenzi O; Caliendo G; Santagada V; Perissutti E; Spisani S; Traniello S; Temussi PA
J Pept Sci; 2001 Apr; 7(4):197-207. PubMed ID: 11354463
[TBL] [Abstract][Full Text] [Related]
20. A common pharmacophoric footprint for AIDS vaccine design.
Pisterer C; Mihailescu D; Smith JC; Reed J
J Med Chem; 2004 Jul; 47(15):3723-9. PubMed ID: 15239651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
